Human Molecular Genetics, 2000, Vol. 9, No. 6 979-986
© 2000 Oxford University Press
Untangling tau-related dementia
Department of Clinical Genetics, Erasmus University, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Abundant cytoplasmic inclusions consisting of aggregated hyperphosphorylated protein tau are a characteristic pathological observation in several neurodegenerative disorders such as Alzheimers disease, Picks disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. The recent finding that mutations in the tau gene are responsible for frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) has provided convincing evidence that tau protein plays a key role in neurodegeneration. In the short period since the identification of pathogenic mutations in tau, remarkable progress has been made in understanding some of the mechanisms by which these mutations lead to neurodegeneration. Understanding the disease processes will hopefully provide us with new leads in developing effective therapies for dementia.
+ Tel: +31 10 4088136; Fax: +31 10 4089489; Email: heutink@kgen.fgg.eur.nl
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. D. Pacheco, M. J. Elrick, and A. P. Lieberman Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis Hum. Mol. Genet., March 1, 2009; 18(5): 956 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vandebroek, D. Terwel, T. Vanhelmont, M. Gysemans, C. Van Haesendonck, Y. Engelborghs, J. Winderickx, and F. Van Leuven Microtubule Binding and Clustering of Human Tau-4R and Tau-P301L Proteins Isolated from Yeast Deficient in Orthologues of Glycogen Synthase Kinase-3beta or cdk5 J. Biol. Chem., September 1, 2006; 281(35): 25388 - 25397. [Abstract] [Full Text] [PDF] |
||||
![]() |
J W Park, J Cai, I McIntosh, E W Jabs, M D Fallin, R Ingersoll, J B Hetmanski, M Vekemans, T Attie-Bitach, M Lovett, et al. High throughput SNP and expression analyses of candidate genes for non-syndromic oral clefts J. Med. Genet., July 1, 2006; 43(7): 598 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Short, D. F. Broderick, A. Patton, Z. Arvanitakis, and N. R. Graff-Radford Different Patterns of Magnetic Resonance Imaging Atrophy for Frontotemporal Lobar Degeneration Syndromes Arch Neurol, July 1, 2005; 62(7): 1106 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zarranz, I. Ferrer, E. Lezcano, M. I. Forcadas, B. Eizaguirre, B. Atares, B. Puig, J. C. Gomez-Esteban, C. Fernandez-Maiztegui, I. Rouco, et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease Neurology, May 10, 2005; 64(9): 1578 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. da Cruz, M. Schwarzel, S. Schulze, M. Niyyati, M. Heisenberg, and D. Kretzschmar Disruption of the MAP1B-related Protein FUTSCH Leads to Changes in the Neuronal Cytoskeleton, Axonal Transport Defects, and Progressive Neurodegeneration in Drosophila Mol. Biol. Cell, May 1, 2005; 16(5): 2433 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Terwel, R. Lasrado, J. Snauwaert, E. Vandeweert, C. Van Haesendonck, P. Borghgraef, and F. Van Leuven Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice J. Biol. Chem., February 4, 2005; 280(5): 3963 - 3973. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ Role of Tau Protein in Both Physiological and Pathological Conditions Physiol Rev, April 1, 2004; 84(2): 361 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hernandez, M. Perez, J. J. Lucas, A. M. Mata, R. Bhat, and J. Avila Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35: IMPLICATIONS FOR ALZHEIMER'S DISEASE J. Biol. Chem., January 30, 2004; 279(5): 3801 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Van Deerlin, L. H. Gill, J. M. Farmer, J. Q. Trojanowski, and V. M-Y. Lee Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics Clin. Chem., October 1, 2003; 49(10): 1717 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rosso, E. van Herpen, Y. A. L. Pijnenburg, N. S. M. Schoonenboom, P. Scheltens, P. Heutink, and J. C. van Swieten Total tau and Phosphorylated tau 181 Levels in the Cerebrospinal Fluid of Patients With Frontotemporal Dementia Due to P301L and G272V tau Mutations Arch Neurol, September 1, 2003; 60(9): 1209 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. DeTure, L.-w. Ko, C. Easson, and S.-H. Yen tau Assembly in Inducible Transfectants Expressing Wild-Type or FTDP-17 tau Am. J. Pathol., November 1, 2002; 161(5): 1711 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tatebayashi, T. Miyasaka, D.-H. Chui, T. Akagi, K.-i. Mishima, K. Iwasaki, M. Fujiwara, K. Tanemura, M. Murayama, K. Ishiguro, et al. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau PNAS, October 15, 2002; 99(21): 13896 - 13901. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Heutink and B. A. Oostra Gene finding in genetically isolated populations Hum. Mol. Genet., October 1, 2002; 11(20): 2507 - 2515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Lovestone Can we afford to develop treatments for dementia? J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 685 - 685. [Full Text] [PDF] |
||||
![]() |
M D Greicius, M D Geschwind, and B L Miller Presenile dementia syndromes: an update on taxonomy and diagnosis J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Short, N. R. Graff-Radford, J. Adamson, M. Baker, and M. Hutton Differences in Tau and Apolipoprotein E Polymorphism Frequencies in Sporadic Frontotemporal Lobar Degeneration Syndromes Arch Neurol, April 1, 2002; 59(4): 611 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delobel, S. Flament, M. Hamdane, R. Jakes, A. Rousseau, A. Delacourte, J.-P. Vilain, M. Goedert, and L. Buee Functional Characterization of FTDP-17 tau Gene Mutations through Their Effects on Xenopus Oocyte Maturation J. Biol. Chem., March 8, 2002; 277(11): 9199 - 9205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Lovestone and D M McLoughlin Protein aggregates and dementia: is there a common toxicity? J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rosso, W. Kamphorst, B. de Graaf, R. Willemsen, R. Ravid, M. F. Niermeijer, M. G. Spillantini, P. Heutink, and J. C. van Swieten Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22 Brain, October 1, 2001; 124(10): 1948 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rizzu, M. Joosse, R. Ravid, A. Hoogeveen, W. Kamphorst, J. C. van Swieten, R. Willemsen, and P. Heutink Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients Hum. Mol. Genet., December 1, 2000; 9(20): 3075 - 3082. [Abstract] [Full Text] [PDF] |
||||











